Bayer traded at 55.52 this Tuesday July 5th, decreasing 1.72 or 3.00 percent since the previous trading session. Looking back, over the last four weeks, Bayer lost 16.74 percent. Over the last 12 months, its price rose by 9.55 percent. Looking ahead, we forecast Bayer to be priced at 55.30 by the end of this quarter and at 49.59 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
55.52
Daily Change
-3.00%
Yearly
9.55%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Covestro 30.79 -1.67 -5.14% -42.66%
Air Liquide 122.44 -5.56 -4.34% -16.74%
Arkema 86.14 -1.86 -2.11% -17.49%
Akzo Nobel 61.38 -1.34 -2.14% -40.49%
Alcon AG 67.84 -0.12 -0.18% 3.92%
Amarin 1.59 0.15 10.42% -62.50%
Artemis Alpha 298.00 1.46 0.49% -33.18%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
BASF 39.33 -2.56 -6.11% -40.45%
Bayer 55.52 -1.72 -3.00% 9.55%
Beiersdorf 98.76 -0.44 -0.44% -4.58%
Corteva Inc 52.10 -2.02 -3.73% 18.17%
Vinci 82.90 -3.50 -4.05% -9.47%
DSM 140.10 1.15 0.83% -11.86%
Essilor 139.50 -0.30 -0.21% -7.98%
Fresenius Medical Care 47.26 -0.40 -0.84% -30.19%
Fresenius 28.53 -0.79 -2.69% -34.89%
Genmab 2,407.00 54.00 2.29% -8.41%
Givaudan 3,462.00 19.00 0.55% -19.75%
GRIFOLS 17.56 -0.28 -1.54% -21.61%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Henkel 60.04 0.08 0.13% -31.99%
Hikma Pharmaceutical 1,638.00 -16.00 -0.97% -35.94%
Johnson Matthey 1,818.50 -83.50 -4.39% -40.10%
Linde 261.70 -9.50 -3.50% 7.50%
Lonza Group 529.60 4.80 0.91% -20.46%
Merck 167.85 2.45 1.48% 1.39%
Novartis 80.91 -0.74 -0.91% -4.31%
Nutrien Ltd 97.37 -4.98 -4.87% 32.30%
Philips 20.07 -0.08 -0.37% -50.12%
PPG Industries 118.76 0.90 0.76% -29.73%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Sanofi 97.12 -1.22 -1.24% 11.93%
SAP 85.43 -0.01 -0.01% -28.99%
Solvay 74.82 -4.04 -5.12% -29.71%
UCB 82.60 -0.04 -0.05% -6.92%
Umicore 31.17 -1.01 -3.14% -39.07%

Indexes Price Day Year
EU50 3427 66.71 1.99% -15.99%
DE40 12640 238.78 1.93% -19.45%

Bayer
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non